MAPT and Alzheimer disease: Mostly known as tumor suppressor gene (Stallings et al., 2006; Kohno et al., 2010), PTPRD was also discovered to have possible functional connections with neurological disorders (Ghani et al., 2012) and may have potential interaction with AD marker tau protein (Shulman et al., 2014).